|
SPTX Seaport Therapeutics Inc 2042347 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-62,600,000.00 |
| Balance Sheet |
|
Current Assets
|
$282,175,000.00 |
|
Assets
|
$441,681,000.00 |
|
Current Liabilities
|
$15,674,000.00 |
|
Liabilities
|
$19,079,000.00 |
|
Equity
|
$422,602,000.00 |
|
Shares Out
|
53530550.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-46,313,000.00 |
|
Investing Cash Flow
|
$-175,652,000.00 |
| Market Analysis |
Market Cap
|
$1,286,874,422.00 |
|
Price
|
$24.04 |
|
BVPS
|
7.89 |
|
PB
|
3.05 |
|
EPS
|
-1.78 |
|
FCF
|
$-46,313,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SPTX documents filed with the SEC.
SPTX Filings
Clear
